Author | Journal | Number of meta-analyzed RCTs | Meta-analysis reported RCT funding | Place in publication of RCT funding | Meta-analysis reported RCT author-industry financial ties | Place in publication of RCT author-industry financial ties | Meta-analysis reported RCT author-industry employment | Quality or risk assessment method of meta-analysis |
---|---|---|---|---|---|---|---|---|
General medicine | ||||||||
Feller et al. [23] | JAMA | 21 | Yes, for each included study | Text (as summary statement—for some but not all included studies—RCTs referenced) Characteristics of included studies table (in article—for each included study) | No | N/A | No | Cochrane |
McIntyre et al. [24] | JAMA | 23 | Yes, for each included study | Characteristics of included studies table (in supplementary material—web link only—no mention in text) | Yes, for some but not all included studiesa | Characteristics of included studies table (in supplementary material—web link only—no mention in text) | No | Cochrane |
Zheng et al. [25] | JAMA | 236 | No | N/A | No | N/A | No | Cochrane |
Cipriani et al. [26] | Lancet | 522 | Yes, for each included studyb | Text (as summary statement—RCTs not referenced) Characteristics of included studies (in supplementary material—web link only—funder name not mentioned) | Noc | N/A | No | Cochrane |
Gayet-Ageron et al. [27] | Lancet | 2 | Yes, for each included study | Abstract | No | N/A | No | Cochrane |
Jinatongthai et al. [28] | Lancet | 40 | No | N/A | No | N/A | No | Cochrane |
Alibhai et al. [29] | Ann Intern Med | 23 | Yes, for each included study | Risk of bias assessment text section (as summary statement—for some but not all included studies—RCTs not referenced) Risk of bias assessment table (in article—for each included study) | No | N/A | No | Cochrane |
Wilson et al. [30] | Ann Intern Med | 10 | Yes, for each included studyd | Risk of bias assessment text section (as summary statement—RCTs referenced) Characteristics of studies included table (in article—for each included study) | No | N/A | No | Cochrane |
Baxi et al. [31] | BMJ | 13 | No | N/A | No | N/A | No | Cochrane |
López-López et al. [32] | BMJ | 23 | Yes, for each included study | Text (as summary statement—RCTs not referenced) Characteristics of included studies table (for each included study—in supplementary material—web link only) | No | N/A | No | Cochrane |
Sadeghirad et al. [33] | BMJ | 10 | No | N/A | No | N/A | No | Cochrane |
General medicine total | 923 | 7/11 (63.6%) | 1/11 (9.1%) | 0/11 (0.0%) | ||||
Specialty medicine | ||||||||
Oncology | ||||||||
McCarthy et al. [34] | J Clin Oncol | 3 | Yes, for each included study | “Support” section at end of article | No | N/A | No | None |
van Beurden-Tan et al. [35] | J Clin Oncol | 17 | No | N/A | No | N/A | No | None |
Abdel-Qadir et al. [36] | Ann Oncol | 16 | No | N/A | No | N/A | No | Cochrane |
Cardiology | ||||||||
Siontis et al. [37] | Circulation | 4 | No | N/A | No | N/A | No | None |
Renda et al. [38] | J Am Coll Cardiol | 4 | No | N/A | No | N/A | No | Cochrane |
Lau et al. [39] | J Am Coll Cardiol | 7 | Yes, for some but not all studiese | Footnote on first 3 pages of article | No | N/A | No | None |
Respiratory medicine | ||||||||
Verberkt et al. [40] | Eur Resp J | 22 | No | N/A | No | N/A | No | Cochrane |
Ding et al. [41] | J Thorac Oncol | 16 | No | N/A | No | N/A | No | None |
Lee et al. [42] | J Thorac Oncol | 3 | No | N/A | No | N/A | No | None |
Endocrinology | ||||||||
Bethel et al. [43] | Lancet Diabetes Endocrinol | 4 | No | N/A | No | N/A | No | Jadad |
de Carvalho et al. [44] | Diabetes Care | 20 | No | N/A | No | N/A | No | Cochrane |
Maiorino et al. [45] | Diabetes Care | 26 | Yes, for each included study | Text (as summary statement—RCTs not referenced) Characteristics of included studies table (in article—for each included study) | No | N/A | No | Cochrane, Jadad |
Gastroenterology | ||||||||
Khera et al. [46] | Gastroenterology | 28 | No | N/A | No | N/A | No | Cochrane |
Nelson et al. [47] | Gut | 21 | No | N/A | No | N/A | No | Cochrane |
Ford et al. [48] | Gut | 13 | No | N/A | No | N/A | No | Cochrane |
Specialty medicine total: | 204 | 3/15 (20.0%) | 0/15 (0.0%) | 0/15 (0.0%) | ||||
Cochrane database of systematic reviews | ||||||||
Tenforde et al. [49] | Cochrane Database Syst Rev | 13 | Yes, for each included study | Risk of bias assessment in main text (as a summary statement—for some but not all included studies—RCTs referenced)f Risk of bias assessment table in characteristics of included studies section (supplementary material—in article—for some but not all included studies)g Characteristics of included studies table (supplementary material—in article—for each included study) | Yes, for each included study | Risk of bias assessment in main text (as a summary statement—for some but not all included studies—studies referenced)f Risk of bias assessment table in characteristics of included studies section (supplementary material—in article—for some but not all included studies)h Characteristics of included studies table (supplementary material—in article—for each included study) | No | Cochrane |
McNicol et al. [50] | Cochrane Database Syst Rev | 11 | Yes, for each included study | Characteristics of included studies table (supplementary material—in article) | No | N/A | No | Cochrane |
Normansell et al. [51] | Cochrane Database Syst Rev | 4 | Yes, for each included study | Text (as a summary statement—RCTs referenced) Characteristics of included studies table (supplementary material—in article—for each included study) | Noi | N/A | No | Cochrane |
Cochrane total | 28 | 3/3 (100%) | 1/3 (33.3%) | 0/3 (0.0%) | ||||
Total | 1155 | 13/29 (44.8%) | 2/29 (6.9%) | 0/29 (0.0%) |